Food And Drug Administration | sciencenewsnet.in

AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts

December 15, 2020 sarah Jonas Aaci, association of american cancer institutes, CDC, Centers for Disease Control and Prevention (CDC), Coronavirus, covid, covid 19 and cancer, Emergency Use Authorization, FDA, Food And Drug Administration, Pfizer, Vaccination, Vaccine

The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.

Feature

UCLA, UCSF gain FDA approval for prostate cancer imaging technique

December 1, 2020 sarah Jonas FDA Approval, Food And Drug Administration, Imaging, prostate cancer

The University of California’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.

Research Results

Mass Eye and Ear Experts Urge Food and Drug Administration to Allow Over-The-Counter Hearing Aid Devices

November 18, 2020 sarah Jonas FDA, Food And Drug Administration, Hearing Aid

Hearing experts advocate in The New England Journal of Medicine for the FDA to implement the Over-the-Counter Hearing Aid Act of 2017. The FDA missed the deadline to release the much-anticipated regulations on August 18, 2020

Feature

Rapid disease pathogen identification a step closer following successful UAH startup demonstration

October 19, 2020 sarah Jonas FDA, Food And Drug Administration, Genetics, UAH, University of Alabama in Huntsville

Soon it could only take an hour to find out what pathogen is making you ill, following the successful demonstration of the world’s first multi-pathogen identification using non-amplified RNA detection by GeneCapture, a company cofounded by researchers at The University of Alabama in Huntsville (UAH).

Feature Expert

Rutgers Experts Urge Ban of Menthol Cigarettes Nationwide

October 9, 2020 sarah Jonas Cigarette, FDA, flavored tobacco, Food And Drug Administration, menthol cigarettes, Tobacco

Rutgers experts discuss why actions at the state and federal level need to be taken to ban menthol-flavored tobacco products

Research Results

Government health, safety regulations backfire with conservatives, study shows

June 10, 2020 sarah Jonas Conservative, Food And Drug Administration, Liberal, Public Policy, Texting and Driving

A new study from the University of Notre Dame shows government-imposed restrictions can backfire, depending on political ideology.

Feature

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology

June 10, 2020 sarah Jonas COVID-19 and Cancer, Food And Drug Administration, health information technolgy, National Comprehensive Cancer Network, NCCN, NCCNPolicy

Online summit from NCCN on 21st Century Cures Act includes bipartisan sponsors, regulatory authorities; examines the impact on and from COVID-19 on cancer care and technology; presents policy recommendations for using data to advance patient access to high-quality cancer care

Feature

Food Safety and Coronavirus

April 27, 2020 sarah Jonas Coronavirus, covid, covid19, Food And Drug Administration, Food Safety, Michigan State University, Microbial, Risk Analysis

Covid Conversations on Risk featuring Jade Mitchell, Ph.D., and Felicia Wu, Ph.D. both from Michigan State University addresses food safety and risk. A recording of the webinar can be found on the SRA website at https://sra.org/covid-19-resources

Policy

New Legislation Would Jeopardize Patient Access to Medical Tests Across the Board by Restricting Policy that Removed Barriers to Coronavirus Testing

March 6, 2020 sarah Jonas Aacc, american association for clinical chemistry, coronavirus testing, Diagnostic Testing, FDA Regulations, Food And Drug Administration

On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and proficiency testing requirements. This bill promotes duplicative, costly federal regulations for clinical laboratories that will result in decreased patient access to essential medical tests. AACC urges Congress not to act on this bill until its impact on healthcare can be thoroughly evaluated.

Policy

AACC Statement on New FDA Guidance That Allows Certified Labs to Perform Coronavirus Testing

March 2, 2020 sarah Jonas Aacc, american association for clinical chemistry, Coronavirus, coronavirus disease 2019, COVID-19, Diagnostic Testing, FDA, FDA Regulations, Food And Drug Administration

AACC thanks the FDA for being responsive to the concerns of the clinical laboratory community and amending the coronavirus guidance to allow CMS-certified labs to develop and implement new tests for coronavirus prior to FDA approval.

Research Results

Researchers Show How Ebola Virus Hijacks Host Lipids

February 15, 2020 sarah Jonas Biophysical Society, Biophysical Society 64th Annual Meeting, Biophysical Society Annual Meeting, BPS, BPS20, Ebola, Ebola Virus, FDA, Food And Drug Administration, Lipids

Robert Stahelin studies some of the world’s deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates. Stahelin, professor at Purdue University, examines how these viruses take advantage of human host cells.

Announcement

ISPOR-FDA Summit 2020 Will Focus on the Use of Patient-Preference Information in Medical Devices

January 28, 2020 sarah Jonas 0 Comments Food And Drug Administration, HEOR, ISPOR, Medical Device, Medical Devices

ISPOR—the professional society for health economics and outcomes research, announced that it will be holding a joint ISPOR-FDA Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” on March 31, 2020 in Silver Spring, MD, USA.

← Previous